| Kathryn E Thigpen, OD | |
|
201 Rosa Ln, Florence, AL 35630-1770 | |
| (256) 760-7213 | |
| (256) 760-7272 |
| Full Name | Kathryn E Thigpen |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 21 Years |
| Location | 201 Rosa Ln, Florence, Alabama |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316994759 | NPI | - | NPPES |
| 009930575 | Medicaid | AL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | SA55TA639 (Alabama) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Florence Eye Center, Inc. | 4082631874 | 6 |
News Archive
Rember—the blue dye that created a stir in 2008 when Phase 2 clinical trial data claimed that it slowed decline in people with Alzheimer's disease—has now been revamped for Phase 3 testing in another disease, behavioral-variant frontotemporal dementia (bvFTD).
TSO3 Inc. an innovator in sterilization technology for medical devices in healthcare settings using ozone, posted revenues of $122,759 for the third quarter of 2010, ended September 30, for the sale of accessories and service contracts.
In the May issue of Mayo Clinic Proceedings, physician experts review current practices for pain management in cirrhotic patients. The physician experts reviewed all current literature available on PubMed and MEDLINE with no limits in the search to recommend a uniform and practical guide to approaching analgesia in the cirrhotic patients.
The U.S. Food and Drug Administration today approved a new indication for Jardiance (empagliflozin) to reduce the risk of cardiovascular death in adult patients with type 2 diabetes mellitus and cardiovascular disease.
› Verified 2 days ago
| Provider Name | Florence Eye Center, Inc. |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1457414104 PECOS PAC ID: 4082631874 Enrollment ID: O20051101000058 |
News Archive
Rember—the blue dye that created a stir in 2008 when Phase 2 clinical trial data claimed that it slowed decline in people with Alzheimer's disease—has now been revamped for Phase 3 testing in another disease, behavioral-variant frontotemporal dementia (bvFTD).
TSO3 Inc. an innovator in sterilization technology for medical devices in healthcare settings using ozone, posted revenues of $122,759 for the third quarter of 2010, ended September 30, for the sale of accessories and service contracts.
In the May issue of Mayo Clinic Proceedings, physician experts review current practices for pain management in cirrhotic patients. The physician experts reviewed all current literature available on PubMed and MEDLINE with no limits in the search to recommend a uniform and practical guide to approaching analgesia in the cirrhotic patients.
The U.S. Food and Drug Administration today approved a new indication for Jardiance (empagliflozin) to reduce the risk of cardiovascular death in adult patients with type 2 diabetes mellitus and cardiovascular disease.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kathryn E Thigpen, OD 201 Rosa Ln, Florence, AL 35630-1770 Ph: (256) 760-7213 | Kathryn E Thigpen, OD 201 Rosa Ln, Florence, AL 35630-1770 Ph: (256) 760-7213 |
News Archive
Rember—the blue dye that created a stir in 2008 when Phase 2 clinical trial data claimed that it slowed decline in people with Alzheimer's disease—has now been revamped for Phase 3 testing in another disease, behavioral-variant frontotemporal dementia (bvFTD).
TSO3 Inc. an innovator in sterilization technology for medical devices in healthcare settings using ozone, posted revenues of $122,759 for the third quarter of 2010, ended September 30, for the sale of accessories and service contracts.
In the May issue of Mayo Clinic Proceedings, physician experts review current practices for pain management in cirrhotic patients. The physician experts reviewed all current literature available on PubMed and MEDLINE with no limits in the search to recommend a uniform and practical guide to approaching analgesia in the cirrhotic patients.
The U.S. Food and Drug Administration today approved a new indication for Jardiance (empagliflozin) to reduce the risk of cardiovascular death in adult patients with type 2 diabetes mellitus and cardiovascular disease.
› Verified 2 days ago
Shoals Eye Clinic Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2126 Helton Dr, Florence, AL 35630 Phone: 256-766-5405 | |
Renaissance Eye Care Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1593 Darby Dr, Florence, AL 35630 Phone: 256-767-5522 Fax: 256-767-6114 | |
None Optometrist Medicare: Not Enrolled in Medicare Practice Location: 201 Rosa Ln, Florence, AL 35630 Phone: 256-760-8484 Fax: 256-760-7272 | |
Dr Sidney I Greenberg Pc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2624 Hough Rd, Florence, AL 35630 Phone: 256-668-3800 | |
Dr. Barry Rayford Basden, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 711 Cox Creek Pkwy, Florence, AL 35630 Phone: 256-766-3139 Fax: 256-767-7374 | |
Renaissance Eye Care Optometrist Medicare: Medicare Enrolled Practice Location: 1593 Darby Dr, Florence, AL 35630 Phone: 256-767-5522 Fax: 256-767-6114 | |
Dr. Benjamin Kachelman, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 711 Cox Creek Pkwy, Florence, AL 35630 Phone: 256-766-3139 Fax: 256-767-7374 |